Updated September 2026Promo past its own end dateSesame Care review
The advertised introductory rate covers two months at the two lowest doses, and it is still displayed past the end date its own terms give.
The verdict
Sesame Care advertises $199 a month for compounded semaglutide, read August 2026, and three conditions sit on that figure. It applies to new self-pay patients, for the first two months only, and at the 0.25 and 0.5mg doses alone. The standing rate is $349. The promotion was still being advertised past the end date stated in its own FAQ terms.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Rises with dose
- Injection
- From $358/mo
- Oral
- From $208/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Sesame Care sells both molecules by injection and semaglutide as a low-dose oral at $149. Its tirzepatide line is priced by dose rather than by a single figure, which is a fuller disclosure than most sellers offer.
Who writes the prescription, and what do they see?
A prescription precedes dispensing and the marketplace model puts a clinician between the buyer and the medication. What the pages do not settle is the eligibility question governing the advertised price. New self-pay patients qualify and returning or insured ones apparently do not, with the boundary drawn in FAQ terms rather than beside the figure.
Three conditions on one advertised number is a lot to carry, and each is disclosed somewhere. The problem is where. A reader meets $199 on the marketing surface and the qualifications in a FAQ, which is the ordinary shape of this failure rather than an unusual one.
What happens when the dose goes up?
The tirzepatide line is the strong disclosure here: $299 at the opening dose, $399 at 5mg, and $449 across 7.5, 10, 12.5 and 15mg. That is a published ladder with milligram figures attached, and it lets a reader price the escalation rather than guess at it. The semaglutide promotion runs the other way, restricting its rate to the two lowest doses.
What the price includes
$199 describes two months at a starting dose, after which the rate is $349. Six months is therefore $398 plus four at $349, which is $1,794, and that assumes the dose does not move past 0.5mg. The tirzepatide ladder is more honest about the same problem: it says outright that the figure rises with the dose and prints what it rises to.
What it claims, and what it cites
The compounded lines have not been through FDA review for safety or quality before dispensing. The oral semaglutide is described as low-dose, so the $149 is not priced against a standard starting dose.
Where it holds up, and where it does not
- Strength: Tirzepatide priced by milligram dose
- Strength: Every condition is disclosed somewhere
- Strength: A low-dose oral is offered and labeled
- Limitation: The promo was advertised past its end date
- Limitation: Three conditions sit on one figure
- Limitation: The standing rate is $150 higher
- Limitation: Conditions live in FAQ terms, not beside the price
What the evidence says about this kind of treatment
The assessment above is about Sesame Care. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants tirzepatide priced by dose and will read the FAQ before the headline.
- Wrong for
- A reader taking the advertised semaglutide figure as a standing rate.
How Sesame Care compares
| Seller | Who it suits | Go |
|---|---|---|
 BioGlow Health | A reader who wants to see the whole ladder before starting, and who can work out which rung they are likely to sit on for most of a year. | See BioGlow Health → |
 PlushCare | A reader with insurance who wants a clinician visit in the loop, and who reads $149 as a starting-dose figure rather than a standing one. | See PlushCare → |
 Embody | A reader willing to read the terms of service before the checkout total, because the low rate and the listed rate are different numbers. | See Embody → |
More GLP-1 telehealth sellers reviews: Ozari HealthPallas HealthPepHaūsPeterMDPlexusDxPreventiveMD
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Who gets the $199?
- New self-pay patients, for the first two months, at the 0.25 and 0.5mg doses. The standing rate afterwards is $349.
- Is the promotion still running?
- It was still being advertised past the end date stated in its own FAQ terms when the pages were read, which is a reason to confirm it applies before ordering.
- What does tirzepatide cost at a higher dose?
- $399 at 5mg and $449 at 7.5mg and above, against $299 at the opening dose. Sesame publishes the ladder with the milligrams attached.
- Is Sesame Care expensive compared with other GLP-1 telehealth sellers?
- Sesame Care publishes a starting figure of $208/mo. Across the 112 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $179, which puts Sesame Care above the median. The other 8 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.